Neurology Central

AAN 2018: Investigational drug offers hope for spinal muscular atrophy

A preliminary, open-label study presented at the American Academy of Neurology’s 70th Annual Meeting (April 21–27, CA, USA) has revealed that an investigational drug may help increase protein levels in babies with spinal muscular atrophy (SMA).
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.